Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqing Qi

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Oncotarget|October 28, 2015
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancerWenqing Qi, Carla Morales, Laurence S Cooke, et al.
Molecular Cancer Therapeutics|June 16, 2017
Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell LymphomasShariful Islam, Wenqing Qi, Carla Morales, et al.
Biologics : Targets & Therapy|October 31, 2025
The Dual Role of the TRAIL-DR5 Signaling Axis in Cardiovascular Disease: From Molecular Mechanisms to Targeted TherapiesRun Cao, Wenqing Qi, Xinyu Huang, et al.
The New Phytologist|March 30, 2010
The Arabidopsis acbp1acbp2 double mutant lacking acyl-CoA-binding proteins ACBP1 and ACBP2 is embryo lethalQin-Fang Chen, Shi Xiao, Wenqing Qi, et al.
International Journal of Cancer|July 29, 2011
AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomasWenqing Qi, Xiaobing Liu, Laurence S Cooke, et al.
BMC Cancer|September 5, 2006
Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicityAshley A Powell, Sandeep Akare, Wenqing Qi, et al.
The Journal of Pathology|March 28, 2022
Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesisWenqing Qi, Wojciech Rosikiewicz, Zhaohong Yin, et al.
BMC Cancer|May 13, 2009
MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancerWenqing Qi, Larry S Cooke, Amy Stejskal, et al.
Molecular Cancer Therapeutics|April 1, 2010
AT7519, a cyclin-dependent kinase inhibitor, exerts its effects by transcriptional inhibition in leukemia cell lines and patient samplesMatthew S Squires, Laurence Cooke, Victoria Lock, et al.
JACS Au|August 1, 2025
Accelerated Crystallization of Zeolites via Solid Boron Free RadicalsJunze Zhuang, Tianjiao Qin, Wenqing Qi, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Oncotarget|October 28, 2015
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancerWenqing Qi, Carla Morales, Laurence S Cooke, et al.
Molecular Cancer Therapeutics|June 16, 2017
Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell LymphomasShariful Islam, Wenqing Qi, Carla Morales, et al.
Biologics : Targets & Therapy|October 31, 2025
The Dual Role of the TRAIL-DR5 Signaling Axis in Cardiovascular Disease: From Molecular Mechanisms to Targeted TherapiesRun Cao, Wenqing Qi, Xinyu Huang, et al.
The New Phytologist|March 30, 2010
The Arabidopsis acbp1acbp2 double mutant lacking acyl-CoA-binding proteins ACBP1 and ACBP2 is embryo lethalQin-Fang Chen, Shi Xiao, Wenqing Qi, et al.
International Journal of Cancer|July 29, 2011
AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B-cell lymphomasWenqing Qi, Xiaobing Liu, Laurence S Cooke, et al.
BMC Cancer|September 5, 2006
Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicityAshley A Powell, Sandeep Akare, Wenqing Qi, et al.
The Journal of Pathology|March 28, 2022
Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesisWenqing Qi, Wojciech Rosikiewicz, Zhaohong Yin, et al.
BMC Cancer|May 13, 2009
MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancerWenqing Qi, Larry S Cooke, Amy Stejskal, et al.
Molecular Cancer Therapeutics|April 1, 2010
AT7519, a cyclin-dependent kinase inhibitor, exerts its effects by transcriptional inhibition in leukemia cell lines and patient samplesMatthew S Squires, Laurence Cooke, Victoria Lock, et al.
JACS Au|August 1, 2025
Accelerated Crystallization of Zeolites via Solid Boron Free RadicalsJunze Zhuang, Tianjiao Qin, Wenqing Qi, et al.
Pageof 4